Pincer Biotech

The aim of Pincer Biotech is to ensure development of new clinical treatments based on frontline research regarding biofilms and persister cells in implant-associated infections conducted at Aarhus University and Aarhus University Hospital. The ultimate goal is to develop a new class of therapeutic compounds that address the critical issue of targeting the antibiotic-tolerant persister cells residing in the biofilm, thus overcoming the limitation that plagues all known antibiotics.

Contact name:

CEO Charlotte Dyring, PhD


Inge Lehmannsgade 10, Aarhus





Number of employees:


If you cannot find what you are looking for or if you have feedback to our website, please do not hesitate to contact or +45 7172 1114

Copyright 2022 DANISH BIO – DANSK BIOTEK. All rights reserved.